Transarterial chemoembolization (TACE) is usually followed by hepatic dysfunction. We evaluated the effects of L-carnitine on
post-TACE impaired liver functions. Methods. 53 cirrhotic hepatocellular carcinoma patients at Osaka Medical College were
enrolled in this study and assigned into either L-carnitine group receiving 600 mg oral L-carnitine daily or control group. Liver
functions were evaluated at pre-TACE and 1, 4, and 12 weeks afer TACE. Results. Te L-carnitine group maintained Child-Pugh
(CP) score at 1 week afer TACE and exhibited signifcant improvement at 4 weeks afer TACE (